Maguinsalog, Ethyl .

HRN: 29-01-41  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2026
CEFUROXIME 1.5GM (VIAL)
06/27/2026
07/04/2026
IV
1.5 Grams
Q8
UTI; Systemic Viral Illness
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines